Clarivate PLC (CLVT) stock
Close on Nov 17, 2026Market cap $1.40BP/E –Yield –
Earnings
Clarivate's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Clarivate's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 23, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 3, 2026before the open | $567.90M | -8.9% | -$0.13 | $0.21 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026before the open | $587.30M | -5.5% | -$0.42 | $0.19 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026before the open | $585.50M | -1.4% | -$0.06 | $0.18 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026before the open | $617.00M | -6.9% | $0.00 | $0.20 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 29, 2025before the open | $623.10M | +0.1% | -$0.04 | $0.18 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 30, 2025before the open | $621.40M | -4.4% | -$0.11 | $0.18 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 29, 2025before the open | $593.70M | -4.4% | -$0.15 | $0.14 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 19, 2025before the open | $663.00M | -3.0% | -$0.27 | $0.21 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 6, 2024before the open | $622.20M | -3.9% | -$0.09 | $0.19 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 6, 2024before the open | $650.30M | -2.8% | -$0.46 | $0.20 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024before the open | $621.20M | -1.3% | -$0.14 | $0.14 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024before the open | $683.70M | +1.2% | -$1.30 | $0.23 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023before the open | $647.20M | +1.8% | -$0.01 | $0.21 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $668.80M | -2.6% | -$0.21 | $0.21 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023before the open | $629.10M | -5.0% | $0.04 | $0.18 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 1, 2023before the open | $675.30M | +20.4% | $0.44 | $0.22 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 8, 2022before the open | $635.70M | +43.8% | -$6.64 | $0.20 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022before the open | $686.60M | – | $0.00 | $0.22 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 9, 2022before the open | $662.20M | – | -$0.06 | $0.21 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 10, 2022before the open | $560.70M | – | -$0.20 | $0.23 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021before the open | $442.10M | – | $0.00 | $0.16 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 29, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 29, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 25, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Clarivate's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| RevenuesGAAP | Q4 FY2026 | $490.00M – $510.00M | – | New | Nov 3, 2026 |
| Adjusted EBITDAnon-GAAP | Q4 FY2026 | $215.00M – $235.00M | – | New | Nov 3, 2026 |
| Adjusted Diluted EPSnon-GAAP | Q4 FY2026 | $0.14 – $0.18 | – | New | Nov 3, 2026 |
| Free Cash Flownon-GAAP | Q4 FY2026 | $85.00M – $105.00M | – | New | Nov 3, 2026 |
| ACV Organic Growthnon-GAAP | Q4 FY2026 | +1.75% – +2.25% | – | New | Nov 3, 2026 |
| Adjusted EBITDA Marginnon-GAAP | Q4 FY2026 | 44% – 46% | – | New | Nov 3, 2026 |
| Recurring Organic Revenue Growthnon-GAAP | Q4 FY2026 | +2% – +2.5% | – | Raised | Nov 3, 2026 |
| Recurring Organic Revenue Growth | FY2026 | +0.75% – +2.25% | – | New | Feb 24, 2026 |
| RevenuesGAAP | FY2026 | $1.97B – $1.99B | – | New | Nov 3, 2026 |
| RevenuesGAAP | FY2026 | $1.94B – $2.04B | – | New | Jul 29, 2026 |
| Revenues | FY2026 | $2.30B – $2.42B | $2.30B – $2.42B | Reaffirmed | Apr 29, 2026 |
| Revenues, Including Discontinued Operationsnon-GAAP | FY2026 | $2.30B – $2.42B | – | New | Jul 29, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $865.00M – $885.00M | – | New | Nov 3, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $980.00M – $1.04M | $980.00M – $1.04B | Lowered | Jul 29, 2026 |
| Net income (loss) per shareGAAP | FY2026 | -$0.65 – -$0.62 | – | New | Nov 3, 2026 |
| Net income (loss) per shareGAAP | FY2026 | -$0.64 – -$0.54 | -$0.29 – -$0.19 | Lowered | Jul 29, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2026 | $0.73 – $0.77 | – | New | Nov 3, 2026 |
| Adjusted Diluted EPSnon-GAAP | FY2026 | $0.70 – $0.80 | $0.70 – $0.80 | Reaffirmed | Jul 29, 2026 |
| Free Cash Flownon-GAAP | FY2026 | $320.00M – $340.00M | – | New | Nov 3, 2026 |
| Free Cash Flownon-GAAP | FY2026 | $365.00M – $435.00M | $365.00M – $435.00M | Reaffirmed | Jul 29, 2026 |
| Capital expendituresGAAP | FY2026 | $230.00M | – | New | Nov 3, 2026 |
| Capital expendituresGAAP | FY2026 | -$245.00M | -$250.00M | Raised | Jul 29, 2026 |
| ACV Organic Growthnon-GAAP | FY2026 | +1.75% – +2.25% | – | New | Nov 3, 2026 |
| ACV Organic Growthnon-GAAP | FY2026 | +2% – +3% | – | New | Jul 29, 2026 |
| Adjusted EBITDA Marginnon-GAAP | FY2026 | 43% – 45% | – | New | Nov 3, 2026 |
| Adjusted EBITDA Marginnon-GAAP | FY2026 | 42% – 43.5% | 42% – 43.5% | Reaffirmed | Jul 29, 2026 |
| Net cash provided by operating activitiesGAAP | FY2026 | $550.00M – $570.00M | – | Raised | Nov 3, 2026 |
| Net cash provided by operating activitiesGAAP | FY2026 | $610.00M – $680.00M | $615.00M – $685.00M | Raised | Jul 29, 2026 |
| Net income (loss)GAAP | FY2026 | -$154.00M – -$144.00M | – | New | Nov 3, 2026 |
| Net income (loss)GAAP | FY2026 | -$418.00M – -$353.00M | -$189.00M – -$124.00M | Lowered | Jul 29, 2026 |
| Net income (loss) marginGAAP | FY2026 | -7.8% – -7.3% | – | New | Nov 3, 2026 |
| Net income (loss) marginGAAP | FY2026 | -8.2% – -5.1% | – | New | Feb 24, 2026 |
| Organic ACV | FY2026 | +2% – +3% | +2% – +3% | Reaffirmed | Apr 29, 2026 |
| Recurring Organic Revenue Growthnon-GAAP | FY2026 | +1% – +1.5% | – | Lowered | Nov 3, 2026 |
| Recurring Organic Revenue Growthnon-GAAP | FY2026 | +0.75% – +2.25% | – | Lowered | Jul 29, 2026 |
| Recurring Organic Revenue Growth | FY2026 | +0.75% – +2.25% | – | Lowered | Apr 29, 2026 |
Guidance history
Every forecast Clarivate put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 3, 2026 | Capital expenditures | FY2026 | $230.00M | New |
| Nov 3, 2026 | Adjusted EBITDA | Q4 FY2026 | $215.00M – $235.00M | New |
| Nov 3, 2026 | Adjusted EBITDA | FY2026 | $865.00M – $885.00M | New |
| Nov 3, 2026 | Adjusted Diluted EPS | Q4 FY2026 | $0.14 – $0.18 | New |
| Nov 3, 2026 | Adjusted Diluted EPS | FY2026 | $0.73 – $0.77 | New |
| Nov 3, 2026 | Net income (loss) per share | FY2026 | -$0.65 – -$0.62 | New |
| Nov 3, 2026 | Free Cash Flow | Q4 FY2026 | $85.00M – $105.00M | New |
| Nov 3, 2026 | Free Cash Flow | FY2026 | $320.00M – $340.00M | New |
| Nov 3, 2026 | Adjusted EBITDA Margin | Q4 FY2026 | 44% – 46% | New |
| Nov 3, 2026 | ACV Organic Growth | Q4 FY2026 | +1.75% – +2.25% | New |
| Nov 3, 2026 | Recurring Organic Revenue Growth | Q4 FY2026 | +2% – +2.5% | Raised |
| Nov 3, 2026 | Net income (loss) margin | FY2026 | -7.8% – -7.3% | New |
| Nov 3, 2026 | Adjusted EBITDA Margin | FY2026 | 43% – 45% | New |
| Nov 3, 2026 | ACV Organic Growth | FY2026 | +1.75% – +2.25% | New |
| Nov 3, 2026 | Recurring Organic Revenue Growth | FY2026 | +1% – +1.5% | Lowered |
| Nov 3, 2026 | Net income (loss) | FY2026 | -$154.00M – -$144.00M | New |
| Nov 3, 2026 | Net cash provided by operating activities | FY2026 | $550.00M – $570.00M | Raised |
| Nov 3, 2026 | Revenues | FY2026 | $1.97B – $1.99B | New |
| Nov 3, 2026 | Revenues | Q4 FY2026 | $490.00M – $510.00M | New |
| Jul 29, 2026 | Capital expenditures | FY2026 | -$245.00M | Raised |
| Jul 29, 2026 | Adjusted EBITDA | FY2026 | $980.00M – $1.04M | Lowered |
| Jul 29, 2026 | Adjusted Diluted EPS | FY2026 | $0.70 – $0.80 | Reaffirmed |
| Jul 29, 2026 | Net income (loss) per share | FY2026 | -$0.64 – -$0.54 | Lowered |
| Jul 29, 2026 | Free Cash Flow | FY2026 | $365.00M – $435.00M | Reaffirmed |
| Jul 29, 2026 | Adjusted EBITDA Margin | FY2026 | 42% – 43.5% | Reaffirmed |
| Jul 29, 2026 | ACV Organic Growth | FY2026 | +2% – +3% | New |
| Jul 29, 2026 | Recurring Organic Revenue Growth | FY2026 | +0.75% – +2.25% | Lowered |
| Jul 29, 2026 | Net cash provided by operating activities | FY2026 | $610.00M – $680.00M | Raised |
| Jul 29, 2026 | Net income (loss) | FY2026 | -$418.00M – -$353.00M | Lowered |
| Jul 29, 2026 | Revenues, Including Discontinued Operations | FY2026 | $2.30B – $2.42B | New |
| Jul 29, 2026 | Revenues | FY2026 | $1.94B – $2.04B | New |
| Apr 29, 2026 | Adjusted EBITDA | FY2026 | $980.00M – $1.04B | Raised |
| Apr 29, 2026 | Adjusted Diluted EPS (1)(2) | FY2026 | $0.70 – $0.80 | Reaffirmed |
| Apr 29, 2026 | Net income (loss) per share | FY2026 | -$0.29 – -$0.19 | Reaffirmed |
| Apr 29, 2026 | Free Cash Flow (1) | FY2026 | $365.00M – $435.00M | Reaffirmed |
| Apr 29, 2026 | Adjusted EBITDA Margin (1) | FY2026 | 42% – 43.5% | Reaffirmed |
| Apr 29, 2026 | Organic ACV | FY2026 | +2% – +3% | Reaffirmed |
| Apr 29, 2026 | Recurring Organic Revenue Growth | FY2026 | +0.75% – +2.25% | Lowered |
| Apr 29, 2026 | Revenues | FY2026 | $2.30B – $2.42B | Reaffirmed |
| Feb 24, 2026 | Capital expenditures | FY2026 | -$250.00M | New |
| Feb 24, 2026 | Adjusted EBITDA | FY2026 | $980.00M – $1.04M | New |
| Feb 24, 2026 | Adjusted Diluted EPS | FY2026 | $0.70 – $0.80 | New |
| Feb 24, 2026 | Net income (loss) | FY2026 | -$0.29 – -$0.19 | New |
| Feb 24, 2026 | Free Cash Flow | FY2026 | $365.00M – $435.00M | New |
| Feb 24, 2026 | Net income (loss) margin | FY2026 | -8.2% – -5.1% | New |
| Feb 24, 2026 | Adjusted EBITDA Margin | FY2026 | 42% – 43.5% | New |
| Feb 24, 2026 | Organic ACV | FY2026 | +2% – +3% | New |
| Feb 24, 2026 | Net income (loss) | FY2026 | -$189.00M – -$124.00M | New |
| Feb 24, 2026 | Net cash provided by operating activities | FY2026 | $615.00M – $685.00M | Raised |
| Feb 24, 2026 | Recurring Organic Revenue Growth | FY2026 | +0.75% – +2.25% | New |
| Feb 24, 2026 | Revenues | FY2026 | $2.30B – $2.42B | New |
| Oct 29, 2025 | Adjusted EBITDA | FY2025 | $940.00M – $1.00B | New |
| Jul 30, 2025 | Capital expenditures | FY2025 | -$255.00M | Lowered |
| Jul 30, 2025 | Adjusted Diluted EPS | FY2025 | $0.60 – $0.70 | Reaffirmed |
| Jul 30, 2025 | Net income (loss) per share | FY2025 | -$0.49 – -$0.39 | Lowered |
| Jul 30, 2025 | Free Cash Flow | FY2025 | $300.00M – $380.00M | Reaffirmed |
| Jul 30, 2025 | Adjusted EBITDA Margin | FY2025 | 40.5% – 42.5% | Reaffirmed |
| Jul 30, 2025 | Net income (loss) margin | FY2025 | -14.6% – -10.7% | New |
| Jul 30, 2025 | Organic ACV | FY2025 | +1% – +2% | Reaffirmed |
| Jul 30, 2025 | Net income (loss) | FY2025 | -$333.00M – -$257.00M | Lowered |
| Jul 30, 2025 | Net cash provided by operating activities | FY2025 | $555.00M – $635.00M | Raised |
| Jul 30, 2025 | Recurring Organic Revenue Growth | FY2025 | -1% – +1% | Reaffirmed |
| Jul 30, 2025 | Revenues | FY2025 | $2.28B – $2.40B | Reaffirmed |
| Apr 29, 2025 | Capital expenditures | FY2025 | -$255.00M | New |
| Apr 29, 2025 | Adjusted EBITDA | FY2025 | $940.00M – $1.00M | Reaffirmed |
| Apr 29, 2025 | Adjusted Diluted EPS | FY2025 | $0.60 – $0.70 | Reaffirmed |
| Apr 29, 2025 | Net income (loss) per share | FY2025 | -$0.28 – -$0.18 | Reaffirmed |
| Apr 29, 2025 | Free Cash Flow | FY2025 | $300.00M – $380.00M | Reaffirmed |
| Apr 29, 2025 | Adjusted EBITDA Margin | FY2025 | 40.5% – 42.5% | Reaffirmed |
| Apr 29, 2025 | Organic ACV | FY2025 | +1% – +2% | New |
| Apr 29, 2025 | Net income (loss) | FY2025 | -$203.00M – -$127.00M | Lowered |
| Apr 29, 2025 | Net cash provided by operating activities | FY2025 | $555.00M – $635.00M | Raised |
| Apr 29, 2025 | Recurring Organic Revenue Growth | FY2025 | -1% – +1% | New |
| Apr 29, 2025 | Revenues | FY2025 | $2.28B – $2.40B | Reaffirmed |
| Feb 19, 2025 | Capital expenditures | FY2025 | $255.00M | New |
| Feb 19, 2025 | Adjusted EBITDA | FY2025 | $940.00M – $1.00M | New |
| Feb 19, 2025 | Adjusted Diluted EPS | FY2025 | $0.60 – $0.70 | New |
| Feb 19, 2025 | Net income (loss) | FY2025 | -$0.28 – -$0.18 | New |
| Feb 19, 2025 | Free Cash Flow | FY2025 | $300.00M – $380.00M | New |
| Feb 19, 2025 | Net income (loss) margin | FY2025 | -8.9% – -5.3% | New |
| Feb 19, 2025 | Adjusted EBITDA Margin | FY2025 | 40.5% – 42.5% | New |
| Feb 19, 2025 | Organic ACV | FY2025 | +1% – +2% | New |
| Feb 19, 2025 | Net income (loss) | FY2025 | -$203.00M – -$127.00M | New |
| Feb 19, 2025 | Net cash provided by operating activities | FY2025 | $555.00M – $635.00M | Raised |
| Feb 19, 2025 | Recurring Organic Revenue Growth | FY2025 | -1% – +1% | New |
| Feb 19, 2025 | Revenues | FY2025 | $2.28B – $2.40B | New |
| Aug 6, 2024 | Adjusted EBITDA | FY2024 | $1.06B – $1.12B | Reaffirmed |
| Aug 6, 2024 | Adjusted Diluted EPS | FY2024 | $0.70 – $0.80 | Reaffirmed |
| Aug 6, 2024 | Free Cash Flow | FY2024 | $420.00M – $500.00M | Reaffirmed |
| Aug 6, 2024 | Adjusted EBITDA Margin | FY2024 | 41% – 42% | Reaffirmed |
| Aug 6, 2024 | Organic Revenue Growth | FY2024 | 0% – +2% | Reaffirmed |
| Aug 6, 2024 | Revenues | FY2024 | $2.57B – $2.67B | Reaffirmed |
| May 8, 2024 | Adjusted EBITDA | FY2024 | $1.06B – $1.12B | Reaffirmed |
| May 8, 2024 | Adjusted diluted EPS | FY2024 | $0.70 – $0.80 | Reaffirmed |
| May 8, 2024 | Free cash flow | FY2024 | $420.00M – $500.00M | Reaffirmed |
| May 8, 2024 | Adjusted EBITDA margin | FY2024 | 41% – 42% | Reaffirmed |
| May 8, 2024 | Organic revenue growth | FY2024 | 0% – +2% | New |
| May 8, 2024 | Revenues | FY2024 | $2.57B – $2.67B | Reaffirmed |
| Feb 27, 2024 | Adjusted EBITDA | FY2024 | $1.06B – $1.12B | New |
| Feb 27, 2024 | Adjusted Diluted EPS | FY2024 | $0.70 – $0.80 | New |
| Feb 27, 2024 | Free Cash Flow | FY2024 | $420.00M – $500.00M | New |
| Feb 27, 2024 | Adjusted EBITDA Margin | FY2024 | 41% – 42% | New |
| Feb 27, 2024 | Organic Revenue Growth | FY2024 | 0% – +2% | New |
| Feb 27, 2024 | Revenues | FY2024 | $2.57B – $2.67B | New |
| Nov 7, 2023 | Adjusted EBITDA | FY2023 | $1.09B – $1.14B | Reaffirmed |
| Nov 7, 2023 | Adjusted Diluted EPS | FY2023 | $0.77 – $0.83 | Reaffirmed |
| Nov 7, 2023 | Free Cash Flow | FY2023 | $450.00M – $500.00M | Reaffirmed |
| Nov 7, 2023 | Adjusted EBITDA Margin | FY2023 | 42% – 42.5% | Reaffirmed |
| Nov 7, 2023 | Organic Revenue Growth | FY2023 | 0% – +2% | Reaffirmed |
| Nov 7, 2023 | Revenues | FY2023 | $2.60B – $2.67B | Reaffirmed |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $1.09B – $1.14B | Lowered |
| Aug 3, 2023 | Adjusted Diluted EPS | FY2023 | $0.77 – $0.83 | Narrowed |
| Aug 3, 2023 | Free Cash Flow | FY2023 | $450.00M – $500.00M | Lowered |
| Aug 3, 2023 | Adjusted EBITDA Margin | FY2023 | 42% – 42.5% | Reaffirmed |
| Aug 3, 2023 | Organic Revenue Growth | FY2023 | 0% – +2% | Lowered |
| Aug 3, 2023 | Revenues | FY2023 | $2.60B – $2.67B | Lowered |
| May 9, 2023 | Adjusted EBITDA | FY2023 | $1.10B – $1.16B | Reaffirmed |
| May 9, 2023 | Adjusted Diluted EPS | FY2023 | $0.75 – $0.85 | Reaffirmed |
| May 9, 2023 | Free Cash Flow | FY2023 | $450.00M – $550.00M | Reaffirmed |
| May 9, 2023 | Adjusted EBITDA Margin | FY2023 | 42% – 42.5% | Reaffirmed |
| May 9, 2023 | Organic Revenue Growth | FY2023 | +2.75% – +3.75% | Reaffirmed |
| May 9, 2023 | Revenues | FY2023 | $2.63B – $2.73B | Reaffirmed |
| Mar 1, 2023 | Adjusted EBITDA | FY2023 | $1.10B – $1.16B | New |
| Mar 1, 2023 | Adjusted Diluted EPS | FY2023 | $0.75 – $0.85 | New |
| Mar 1, 2023 | Free Cash Flow | FY2023 | $450.00M – $550.00M | New |
| Mar 1, 2023 | Adjusted EBITDA Margin | FY2023 | 42% – 42.5% | New |
| Mar 1, 2023 | Organic Revenue Growth | FY2023 | +2.75% – +3.75% | New |
| Mar 1, 2023 | Revenues | FY2023 | $2.63B – $2.73B | New |
| Nov 8, 2022 | Adjusted EBITDA | FY2022 | $1.05B – $1.10B | Lowered |
| Nov 8, 2022 | Adjusted Diluted EPS | FY2022 | $0.75 – $0.85 | Lowered |
| Nov 8, 2022 | Adjusted Free Cash Flow | FY2022 | $500.00M – $550.00M | Lowered |
| Nov 8, 2022 | Adjusted EBITDA margin | FY2022 | 40.5% – 41.5% | Lowered |
| Nov 8, 2022 | Revenues | FY2022 | $2.60B – $2.66B | Lowered |
| Aug 9, 2022 | Adjusted EBITDA | FY2022 | $1.12B – $1.16B | Lowered |
| Aug 9, 2022 | Adjusted Diluted EPS | FY2022 | $0.80 – $0.90 | Lowered |
| Aug 9, 2022 | Adjusted Free Cash Flow | FY2022 | $600.00M – $650.00M | Lowered |
| Aug 9, 2022 | Adjusted EBITDA margin | FY2022 | 41% – 42% | Reaffirmed |
| Aug 9, 2022 | Revenues | FY2022 | $2.70B – $2.76B | Lowered |
| May 9, 2022 | Adjusted EBITDA | FY2022 | $1.16B – $1.22B | Reaffirmed |
| May 9, 2022 | Adjusted Diluted EPS | FY2022 | $0.85 – $0.95 | Reaffirmed |
| May 9, 2022 | Adjusted Free Cash Flow | FY2022 | $675.00M – $725.00M | Reaffirmed |
| May 9, 2022 | Adjusted EBITDA margin | FY2022 | 41% – 42% | Reaffirmed |
| May 9, 2022 | Revenues | FY2022 | $2.80B – $2.88B | Reaffirmed |
| Mar 10, 2022 | Adjusted EBITDA | FY2022 | $1.16B – $1.22B | New |
| Mar 10, 2022 | Adjusted Diluted EPS | FY2022 | $0.85 – $0.95 | New |
| Mar 10, 2022 | Adjusted Free Cash Flow | FY2022 | $675.00M – $725.00M | New |
| Mar 10, 2022 | Adjusted EBITDA margin | FY2022 | 41% – 42% | New |
| Mar 10, 2022 | Revenues | FY2022 | $2.80B – $2.88B | New |
| Oct 28, 2021 | Adjusted EBITDA | FY2021 | $795.00M – $825.00M | New |
| Oct 28, 2021 | Adjusted Diluted EPS | FY2021 | $0.70 – $0.74 | New |
| Oct 28, 2021 | Adjusted Free Cash Flow | FY2021 | $450.00M – $500.00M | New |
| Oct 28, 2021 | Adjusted EBITDA margin | FY2021 | 44% – 45% | New |
| Oct 28, 2021 | Adjusted Revenues | FY2021 | $1.80B – $1.84B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Clarivate filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- Results
- Results
- News
- News
- News
- News
- Update
- Results
- Results
- Update
- Update
- Update
See a number that looks wrong?